The company recently received 510(k) clearance from the Food and Drug Administration to market lateral access implants and plans to introduce these products later this year.
More Articles on Devices:
7 Recent Orthopedic Device Company Expansions & Agreements
U.S. Spine Market Worth $5.5B, $1.5B From Minimally Invasive Devices
Lanx Launches TIMBERLINE Lateral Interbody Spine Fusion Device
